Fulgent Genetics, Inc.FLGTEarnings & Financial Report
Nasdaq
NextMar 13, 2026
FLGT Q3 2025 Key Financial Metrics
Revenue
$84.1M
Gross Profit
$35.5M
Operating Profit
$-15.3M
Net Profit
$-6.6M
Gross Margin
42.2%
Operating Margin
-18.3%
Net Margin
-7.9%
YoY Growth
17.2%
Financial Flow
Fulgent Genetics, Inc. Q3 2025 Financial Summary
Fulgent Genetics, Inc. reported revenue of $84.1M for Q3 2025, with a net profit of $-6.6M (-7.9% margin). Cost of goods sold was $48.6M, operating expenses totaled $50.9M.
Key Financial Metrics
| Total Revenue | $84.1M |
|---|---|
| Net Profit | $-6.6M |
| Gross Margin | 42.2% |
| Operating Margin | -18.3% |
| Report Period | Q3 2025 |
Fulgent Genetics, Inc. Annual Revenue by Year
Fulgent Genetics, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $283.5M).
| Year | Annual Revenue |
|---|---|
| 2024 | $283.5M |
| 2023 | $289.2M |
| 2022 | $619.0M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $70.5M | $64.5M | $71.0M | $71.7M | $76.2M | $73.5M | $81.8M | $84.1M |
| YoY Growth | 4.1% | -2.5% | 4.7% | -15.3% | 8.1% | 13.9% | 15.2% | 17.2% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.24B | $1.23B | $1.23B | $1.23B | $1.22B | $1.21B | $1.20B | $1.21B |
| Liabilities | $102.0M | $103.2M | $103.4M | $98.9M | $90.8M | $83.0M | $88.2M | $93.8M |
| Equity | $1.14B | $1.13B | $1.13B | $1.14B | $1.13B | $1.13B | $1.12B | $1.13B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $14.9M | $7.3M | $4.3M | $-15.5M | $25.0M | $-4.4M | $-30.2M | $11.1M |